1-10 of 10
Scott M. Lippman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

JAK: Not Just Another Kinase

Ruchi P. Agashe, Scott M. Lippman, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (12): 1757–1764.
https://doi.org/10.1158/1535-7163.MCT-22-0323
Published: 02 December 2022
View article titled, JAK: Not Just Another Kinase
Open the PDF for JAK: Not Just Another Kinase in another window
Journal Articles

Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics

In Sil Choi, Shumei Kato, Paul T. Fanta, Lawrence Leichman, Ryosuke Okamura, Victoria M. Raymond, Richard B. Lanman, Scott M. Lippman, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2019) 18 (10): 1852–1862.
https://doi.org/10.1158/1535-7163.MCT-18-0965
Published: 01 October 2019
View article titled, Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics
Open the PDF for Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics in another window
Includes: Supplementary data
Journal Articles

Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology

Hatim Husain, David Nykin, Nam Bui, Daniel Quan, German Gomez, Brian Woodward, Sumathi Venkatapathy, Radha Duttagupta, Eric Fung, Scott M. Lippman, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2017) 16 (5): 948–955.
https://doi.org/10.1158/1535-7163.MCT-16-0436
Published: 02 May 2017
View article titled, Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology
Open the PDF for Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology in another window
Includes: Supplementary data
Journal Articles

Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience

Maria Schwaederle, Barbara A. Parker, Richard B. Schwab, Gregory A. Daniels, David E. Piccioni, Santosh Kesari, Teresa L. Helsten, Lyudmila A. Bazhenova, Julio Romero, Paul T. Fanta, Scott M. Lippman, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2016) 15 (4): 743–752.
https://doi.org/10.1158/1535-7163.MCT-15-0795
Published: 05 April 2016
View article titled, Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience
Open the PDF for Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience in another window
Includes: Supplementary data
Journal Articles

Global Evaluation of Eph Receptors and Ephrins in Lung Adenocarcinomas Identifies EphA4 as an Inhibitor of Cell Migration and Invasion

Pierre Saintigny, Shaohua Peng, Li Zhang, Banibrata Sen, Ignacio I. Wistuba, Scott M. Lippman, Luc Girard, John D. Minna, John V. Heymach, Faye M. Johnson
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (9): 2021–2032.
https://doi.org/10.1158/1535-7163.MCT-12-0030
Published: 06 September 2012
View article titled, Global Evaluation of Eph Receptors and Ephrins in Lung Adenocarcinomas Identifies EphA4 as an Inhibitor of Cell Migration and Invasion
Open the PDF for Global Evaluation of Eph Receptors and Ephrins in Lung Adenocarcinomas Identifies EphA4 as an Inhibitor of Cell Migration and Invasion in another window
Includes: Supplementary data
Journal Articles

Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin–like Growth Factor I Receptor Monoclonal Antibody

Dong Hoon Shin, Hye-Young Min, Adel K. El-Naggar, Scott M. Lippman, Bonnie Glisson, Ho-Young Lee
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (12): 2437–2448.
https://doi.org/10.1158/1535-7163.MCT-11-0235
Published: 07 December 2011
View article titled, Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin–like Growth Factor I Receptor Monoclonal Antibody
Open the PDF for Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin–like Growth Factor I Receptor Monoclonal Antibody in another window
Includes: Supplementary data
Journal Articles

Serum Signature of Hypoxia-Regulated Factors Is Associated with Progression after Induction Therapy in Head and Neck Squamous Cell Cancer

Lauren Averett Byers, F. Christopher Holsinger, Merrill S. Kies, William N. William, Adel K. El-Naggar, J. Jack Lee, Jianhua Hu, Adriana Lopez, Hai T. Tran, Shaoyu Yan, Zhiqiang Du, K. Kian Ang, Bonnie S. Glisson, Maria Gabriela Raso, Ignacio I. Wistuba, Jeffrey N. Myers, Waun-Ki Hong, Vali Papadimitrakopoulou, Scott M. Lippman, John V. Heymach
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (6): 1755–1763.
https://doi.org/10.1158/1535-7163.MCT-09-1047
Published: 09 June 2010
View article titled, Serum Signature of Hypoxia-Regulated Factors Is Associated with Progression after Induction Therapy in Head and Neck Squamous Cell Cancer
Open the PDF for Serum Signature of Hypoxia-Regulated Factors Is Associated with Progression after Induction Therapy in Head and Neck Squamous Cell Cancer in another window
Journal Articles

Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells

Ralph G. Zinner, Brittany L. Barrett, Elmira Popova, Paul Damien, Andrei Y. Volgin, Juri G. Gelovani, Reuben Lotan, Hai T. Tran, Claudio Pisano, Gordon B. Mills, Li Mao, Waun K. Hong, Scott M. Lippman, John H. Miller
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (3): 521–532.
https://doi.org/10.1158/1535-7163.MCT-08-0937
Published: 13 March 2009
View article titled, Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells
Open the PDF for Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells in another window
Includes: Supplementary data
Journal Articles

The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells

Linda C. Hsi, Xiaopei Xi, Yuanqing Wu, Scott M. Lippman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2005) 4 (11): 1740–1746.
https://doi.org/10.1158/1535-7163.MCT-05-0218
Published: 07 November 2005
View article titled, The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells
Open the PDF for The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells in another window
Journal Articles

Dominant Negative Signal Transducer and Activator of Transcription 2 (STAT2) Protein: Stable Expression Blocks Interferon α Action in Skin Squamous Cell Carcinoma Cells

John L. Clifford, Xiulan Yang, Eugene Walch, Michael Wang, Scott M. Lippman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2003) 2 (5): 453–459.
Published: 01 May 2003
View article titled, Dominant Negative Signal Transducer and Activator of Transcription 2 (STAT2) Protein: Stable Expression Blocks Interferon α Action in Skin Squamous Cell Carcinoma Cells
Open the PDF for Dominant Negative Signal Transducer and Activator of Transcription 2 (STAT2) Protein: Stable Expression Blocks Interferon α Action in Skin Squamous Cell Carcinoma Cells in another window